BioTech 365

DECEMBER 30, 2020

Global Research Antibodies and Reagents Market Report 2020-2030: COVID-19 Growth and Change – Market is Expected to Stabilize and Reach $13.19

Reagent 40

Reagent Antibody Marketing Research 40

BioTech 365

OCTOBER 8, 2021

Global Real Time PCR Market Research Report 2021 – ResearchAndMarkets.com Global Real Time PCR Market Research Report 2021 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Real Time PCR Market, By Product (Reagents & Consumables, Instruments, Software & Services), By Application (Clinical Diagnostics, (..)

Marketing 40

Marketing Reagent Research Production 40

ProRelix Research

JUNE 26, 2023

As per Section 201(h)(1) of the Food, Drug, and Cosmetic Act, a device is an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, […] The post US FDA Medical Device Applications appeared first on ProRelix Research.

Reagent 52

Reagent Cosmetics In-Vitro Drugs 52

Drug Discovery World

SEPTEMBER 28, 2022

Beckman Coulter Life Sciences has released a call for registrations for its SPRI Grants for Genomic Research, which the company describes as part of its commitment to the next generation of researchers and scientists. . We’re proud to be a part of the journey of researchers and are eager to review submissions.” .

Genome 52

Genome Genomics Research Life Science 52

Roots Analysis

APRIL 5, 2023

Current Market for Non-Viral Transfection Reagents and Systems Developers Close to 65% of non-viral transfection reagents and systems developers are headquartered in North America. Currently, highest number of patent for non-viral transfection reagents and systems is filed in North America region.

Reagent 52

Reagent Marketing Gene Therapy Gene 52

Drug Discovery World

AUGUST 11, 2023

GenScript Biotech and T-MAXIMUM Biotech have formed a strategic collaboration to develop T-MAXIMUM’s CAR-T cell therapy using GenScript’s CRISPR nucleic acid reagents. GenScript will provide various CRISPR reagents to support the development of the universal CAR-T products from discovery to commercialisation.

Reagent 52

Reagent Development Gene Editing Production 52

Drug Discovery World

MAY 2, 2023

Are you conducting cutting-edge research that’s driving real-world benefits? Tecan want to reward your groundbreaking work through the We can with Tecan competition, launched to highlight the very best in NGS-based research. For research use only. Are you pushing the boundaries of what’s possible with NGS? Submit your abstract.

Reagent 52

Reagent Research Production Drugs 52

Roots Analysis

JUNE 1, 2022

The pandemic has specifically resulted in enhanced research and development activities in the field of biotechnology. Recent technological advancements have led to development of novel DNA cloning kits and reagents, which are cost-effective, faster and more efficient than conventional methods. DNA Cloning Reagents Market.

DNA 52

DNA Genetics Reagent Marketing 52

Scienmag

MAY 18, 2021

(Boston)–Researchers from Boston University School of Medicine (BUSM) report the formation of human cells containing a green fluorescent protein or GFP (one of the most important proteins in biology and fluorescence imaging) genetically fused with two interferon stimulated genes (ISGs), namely Viperin and ISG15.

Immune Response 41

Immune Response Reagent Research Protein 41

Drug Discovery World

OCTOBER 1, 2022

With an unrivalled research product portfolio and end-to-end manufacturing services, we are science led and customer focused to solve problems and deliver key reagents across complex chemicals, peptides and key biologics all from one trusted partner. Biosynth is at the edge of innovation.

Reagent 52

Reagent Life Science Manufacturing Production 52

Scienmag

MARCH 5, 2021

Researchers develop a low-cost and fast method to detect a COVID-19 infection from a pool of gargle lavage samples Credit: MPI f. However, it requires expensive laboratory equipment and global shortages of reagents […]. However, it requires expensive laboratory equipment and global shortages of reagents […].

Development 94

Development Reagent RNA Research 94

BioTech 365

OCTOBER 13, 2020

Food analysis and biotechnology company licenses gene editing technology DUBLIN & KANAGAWA, Japan–(BUSINESS WIRE)–ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has … Continue (..)

Genome 52

Genome Genomics Reagent Gene Editing 52

Drug Discovery World

MARCH 27, 2023

Cell therapy research has never been more exciting with all of the research ongoing. Download this new white paper ‘Diving deep into cell therapy: An industry perspective’ to find out more. The post New whitepaper: Take a deep dive into cell therapy appeared first on Drug Discovery World (DDW).

Reagent 52

Reagent Manufacturing Development Research 52

STAT News

AUGUST 26, 2022

This time around, we note that  Ansa Biotechnologies hired Jeremiah Hanes as senior vice president, research and development. Previously, he worked at PacBio, where he was most recently vice president, reagents R&D. And here is our regular feature in which we highlight a different person each week.

Reagent 98

Reagent Development Research 98

Drug Discovery World

MARCH 27, 2023

Cell therapy research has never been more exciting with all of the research ongoing.

Reagent 52

Reagent Manufacturing Development Drugs 52

Drug Discovery World

NOVEMBER 22, 2022

To support vaccine research and development, The Native Antigen Company has developed Haemagglutinin and Neuraminidase antigens for the WHO-recommended, egg-based and recombinant vaccine strains. . The latest range of antigens can be used in immunoassay development and as immunogens, and includes reagents for both influenza A and B. .

Vaccination 52

Vaccination Vaccine Development Reagent 52

Drug Discovery World

MAY 25, 2023

The platform works with the SYNTAX Hi-Fidelity reagent kits for synthesising longer oligos. The modular, cloud native Torx platform enables chemistry teams to collaborate and share molecules, both internally and with contract research organisations (CROs) around the world.

Production 52

Production Reagent DNA Drugs 52

BioTech 365

FEBRUARY 16, 2021

PerkinElmer Launches First Cell Painting Kit PerkinElmer Launches First Cell Painting Kit New PhenoVue™ cell painting reagent kit makes the process of “painting” cells easier for research scientists by providing carefully selected and pre-optimized reagents WALTHAM, Mass.–(BUSINESS

Reagent 52

Reagent Scientist Research 52

Drug Discovery World

SEPTEMBER 25, 2023

IDT will stock and sell three additional research use only (RUO) and current good manufacturing practice (cGMP) CRISPR nucleases with unique performance characteristics, manufactured by Aldevron, to provide researchers with an accelerated path to the clinic.

Genome 52

Genome Genomics Gene Editing Medicine 52

BioTech 365

SEPTEMBER 22, 2020

Predictive Oncology now has a total of 96 unique Patient Derived Cells (PDCs) from Ovarian Cancer Patients. EAGAN, Minn., 22, 2020 (GLOBE NEWSWIRE) — TumorGenesis, a division of Predictive Oncology (NASDAQ:POAI), a knowledge-driven company focused on applying artificial intelligence … Continue reading →

Reagent 40

Reagent Licensing Licensing Research 40

Scienmag

OCTOBER 15, 2020

Credit: LIU Hongji A joint research team led by Prof. WANG Hui and Prof.

Reagent 85

Reagent Scientist Development Research 85

FDA Law Blog

JANUARY 4, 2023

Brevig, Senior Regulatory Device and Biologics Expert — On December 7, 2022, FDA’s Center for Biologics Evaluation and Research (CBER) and the Office of Tissues and Advanced Therapies (OTAT) held a town hall to answer questions related to cell therapy and tissue-engineered products chemistry, manufacturing, and contr­­ols (CMC). By Holly N.

Reagent 59

Reagent Manufacturing Production Gene Therapy 59

Drug Discovery World

FEBRUARY 6, 2023

Users can add the dedicated CAS SciFinder plugin window to their Torx design environment to search and display the results in CAS SciFinder, alongside real-time critical physico-chemical, near-neighbor, and 3D-pose information about their small molecules in Torx.

Reagent 52

Reagent Drugs Medicine Research 52

BioTech 365

JUNE 30, 2021

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement License agreement to enhance Nippon Gene’s CRISPR/Cas9 research reagents offering DUBLIN & TOKYO–(BUSINESS WIRE)–ERS Genomics Limited, which was formed to provide broad … Continue reading →

Genome 52

Genome Genomics Licensing Licensing 52

BioTech 365

AUGUST 16, 2021

SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline Additional research reagents to detect mutations associated with delta variant of concern now available SYDNEY–(BUSINESS WIRE)–#COVID19–SpeeDx Pty.

Reagent 52

Reagent Development Research 52

BioTech 365

SEPTEMBER 7, 2020

Avacta to make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus CAMBRIDGE & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce … Continue reading →

Reagent 52

Reagent Research Development 52

Drug Discovery World

AUGUST 11, 2023

The news headlines this week reflect the level of interest in cell & gene therapies (CGT) in the sector, particularly CAR-T, but also the importance of research collaborations to bring these therapies to patients. News round-up for by DDW Digital Content Editor Diana Spencer.

Gene Therapy 52

Gene Therapy Drugs Clinical Trials Clinical Trials 52

BioTech 365

FEBRUARY 23, 2021

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which … Continue reading →

Life Science 52

Life Science Genome Genomics Licensing 52

BioTech 365

DECEMBER 22, 2020

SEATTLE–(BUSINESS WIRE)–LSBio (LSBio™), a leading provider of antibodies and life science research reagents, is pleased to announce its acquisition of Redcar, UK-based Absolute Antibody, Ltd. LSBio Acquires Absolute Antibody Ltd. LSBio Acquires Absolute Antibody Ltd. and its sister company Kerafast.

Antibody 52

Antibody Reagent Life Science Research 52

pharmaphorum

NOVEMBER 26, 2020

London-based Salient was founded by former team members of Imperial College’s London BioFoundry, which handled the spin-out and accelerates commercialisation of synthetic biology research and technology.

Reagent 93

Reagent Vaccination Vaccine Development 93

Drug Discovery World

AUGUST 30, 2023

Founded in 1998 and headquartered in Cambridge, UK, Abcam provides antibodies, reagents, biomarkers and assays for drug discovery, life sciences research, and diagnostics. The transaction has been unanimously approved and recommended by the Abcam Board of Directors and unanimously approved by the Danaher Board of Directors.

Life Science 52

Life Science Reagent Branding Antibody 52

Drug Discovery World

MAY 10, 2023

Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers from pharma and biotech, diagnostic labs, academia and government agencies. Revvity has now officially launched as a science-based solutions company.

Life Science 52

Life Science Reagent Genome Genomics 52

Drug Discovery World

MAY 10, 2023

Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers from pharma and biotech, diagnostic labs, academia and government agencies. Revvity has now officially launched as a science-based solutions company.

Life Science 52

Life Science Reagent Genome Genomics 52

Drug Discovery World

NOVEMBER 2, 2023

Fiona Elwood will explore some of the latest advancements in Alzheimer’s disease research, which includes data science techniques, digital health tools and novel biomarkers, while highlighting the unmet needs in developing treatments for Alzheimer’s disease that target the underlying causes of the condition.

Reagent 52

Reagent Drugs Development Medicine 52

Drug Discovery World

OCTOBER 26, 2023

Fiona Elwood will explore some of the latest advancements in Alzheimer’s disease research, which includes data science techniques, digital health tools and novel biomarkers, while highlighting the unmet needs in developing treatments for Alzheimer’s disease that target the underlying causes of the condition.

Reagent 52

Reagent Drugs Development Medicine 52

Drug Discovery World

OCTOBER 19, 2023

Fiona Elwood will explore some of the latest advancements in Alzheimer’s disease research, which includes data science techniques, digital health tools and novel biomarkers, while highlighting the unmet needs in developing treatments for Alzheimer’s disease that target the underlying causes of the condition.

Reagent 52

Reagent Drugs Development Medicine 52

Drug Discovery World

OCTOBER 12, 2023

Fiona Elwood will explore some of the latest advancements in Alzheimer’s disease research, which includes data science techniques, digital health tools and novel biomarkers, while highlighting the unmet needs in developing treatments for Alzheimer’s disease that target the underlying causes of the condition.

Reagent 52

Reagent Drugs Development Medicine 52